Atrial Fibrillation – Regeneron R75098-CVA-24114
Because Every Beat Counts
Consider joining a research study for Atrial Fibrillation.
Profound Research is enrolling an Atrial Fibrillation study that is assessing an investigational medication to see if it reduces stroke and systemic embolism events.
To be eligible to participate, you must:
- Be at least 18 years of age
- Be diagnosed with atrial fibrillation or atrial flutter
- Be willing and able to take anticoagulation therapy
- Not have any of the following:
-
- A mechanical heart valve
-
- Chronic kidney disease
-
- Active endocarditis
-
- Active liver disease
Additional criteria apply.
Qualified participants will receive:
- Study-related care and study medication at no cost
- Financial compensation for time and travel expenses
Call us or complete the form and our team will reach out soon to help determine your eligibility.
Michigan: 248-282-3640
